Showing 1,277 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Sangamo BioSciences Reports Updated Clinical Data from ZFP Therapeutic® Program for HIV/AIDS

Editor's pick
Sangamo press release
22 September 2015
New & experimental HIV treatments

Five Promising HIV Drugs in the Pipeline

Editor's pick
The Body Pro
21 September 2015
Pharmaceutical industry

Fair Pricing Coalition Sign-on Letter to Gilead on Pricing of TAF

Editor's pick
TAG
10 September 2015
New & experimental HIV treatments

Tenofovir Alafenamide Combo Pill Matches Truvada for HIV Efficacy, but Easier on Bones and Kidneys

Editor's pick
HIVandHepatitis.com
4 September 2015
Adherence

The Silent Struggle of HIV Treatment Adherence

Editor's pick
The Body
28 August 2015
Pharmaceutical industry

European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment

Editor's pick
Gilead press release
21 August 2015
New & experimental HIV treatments

'Tweezer' molecule can block HIV in semen, study says

Editor's pick
RT.com
19 August 2015
Access to healthcare

Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry

Editor's pick
Intellectual Property Watch
4 August 2015
Pharmaceutical industry

GSK flags up pipeline as HIV drugs help it beat profit forecasts

Editor's pick
Reuters
30 July 2015
Changing treatment

Switching to new tenofovir alafenamide keeps virus in check and improves kidney and bone health

News
28 July 2015
HIV treatment

New NNRTI doravirine suppresses HIV as well as efavirenz but with fewer central nervous system side-effects

News
23 July 2015
HIV treatment

Next-generation maturation inhibitor BMS-955176 shows good antiviral activity in combination with atazanavir

News
22 July 2015
The search for a cure

Targets proliferate in HIV cure research

News
21 July 2015
The search for a cure

New drug holds out promise of long-term control or even cure of HIV

News
18 July 2015
Pharmaceutical industry

TAG Pipeline Report

Editor's pick
TAG
17 July 2015
New & experimental HIV treatments

Evidence of HIV Suppression With PRO 140 Monotherapy Reaching Nearly 11 Months

Editor's pick
CytoDyn press release
16 July 2015
New & experimental HIV treatments

Scripps Research Institute-Designed Drug Candidate Significantly Reduces HIV Reactivation Rate

Editor's pick
Scripps Research Institute
11 July 2015
PrEP

Could a Subdermal Implant Mean the End of HIV?

Editor's pick
Edge San Francisco
6 July 2015
New & experimental HIV treatments

Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide

Editor's pick
Gilead press release
2 July 2015
Treatment guidelines

New British guidelines recommend treatment for everyone with HIV

News
24 June 2015
New & experimental HIV treatments

European Medicines Agency Validates Gilead’s Marketing Application for Fixed-Dose Combination of Emtricitabine and Tenofovir Alafenamide (F/TAF) for HIV Treatment

Editor's pick
Gilead
2 June 2015
Access to healthcare

ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV

Editor's pick
ViiV Healthcare
26 May 2015
New & experimental HIV treatments

EMA Panel Recommends Evotaz for Adults With HIV-1

Editor's pick
Medscape
26 May 2015
New & experimental HIV treatments

New subdermal implant delivers potent antiretroviral drugs

Editor's pick
Science Daily
29 April 2015